Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 401.95M P/E - EPS this Y -18.50% Ern Qtrly Grth -
Income -126.68M Forward P/E -3.11 EPS next Y 2.50% 50D Avg Chg 9.00%
Sales 32.04M PEG - EPS past 5Y - 200D Avg Chg 38.00%
Dividend N/A Price/Book 3.01 EPS next 5Y - 52W High Chg -2.00%
Recommedations 2.20 Quick Ratio 8.69 Shares Outstanding 48.02M 52W Low Chg 208.00%
Insider Own 3.77% ROA -38.53% Shares Float 43.66M Beta 0.52
Inst Own 77.05% ROE -108.68% Shares Shorted/Prior 1.08M/2.17M Price 8.37
Gross Margin -220.53% Profit Margin - Avg. Volume 2,542,039 Target Price 13.00
Oper. Margin -287.97% Earnings Date Aug 2 Volume Change 0.00%
About Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of March 6, 2023, Concert Pharmaceuticals, Inc. operates as a subsidiary of Sun Pharmaceutical Industries Limited.

CNCE Chatroom

User Image TrendyChart Posted - 10/26/23

Upcoming Earnings Report: $CNCE Concert Pharmaceuticals will be reporting on 11/06/2023 at 7:00AM | Will this stock deliver favorable or unfavorable earnings?

User Image gsocca Posted - 08/05/23

@purotango In today's environment, a buyout would be in the cards. Something similar happened to Concert $CNCE. Also possible, that big money jump on board like Ambrx Biopharma $AMAM. Citi has a TP @ $ 12, often they are right ...

User Image Eliaszero Posted - 06/23/23

$NUGT $CNCE $FWBI $ADV OMG FDA news is coming soon $FWBI

User Image MarketBeat Posted - 04/13/23

Concert Pharmaceuticals initiated by StockNews.com at sell. www.marketbeat.com/stocks/NASDAQ/CNCE/price-target/ $CNCE

User Image MarketBeat Posted - 04/05/23

Concert Pharmaceuticals initiated by StockNews.com at sell. www.marketbeat.com/stocks/NASDAQ/CNCE/price-target/ $CNCE

User Image MarketBeat Posted - 03/28/23

Concert Pharmaceuticals initiated by StockNews.com at sell. www.marketbeat.com/stocks/NASDAQ/CNCE/price-target/ $CNCE

User Image macroaxis Posted - 03/27/23

Concert Pharmaceuticals ( $CNCE ) buy or sell recommendation is NOT RATED https://www.macroaxis.com/stock/CNCE/Concert-Pharmaceuticals #trading #ideas #stocks

User Image risenhoover Posted - 03/27/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/26/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/25/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/24/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/23/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/21/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/20/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image MarketBeat Posted - 03/20/23

Concert Pharmaceuticals initiated by StockNews.com at sell. www.marketbeat.com/stocks/NASDAQ/CNCE/price-target/ $CNCE

User Image risenhoover Posted - 03/19/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/18/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/17/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image Quantisnow Posted - 03/16/23

$CNCE 📜 SEC Form 15-12G filed by Concert Pharmaceuticals Inc. https://quantisnow.com/i/4210760?utm_source=stocktwits 45 seconds delayed.

User Image risenhoover Posted - 03/15/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/14/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image intratio Posted - 03/14/23

Concert Pharmaceuticals Inc The algorithm assessed the value of this stock has a negative short-term outlook and will have a very negative trend in the upcoming months $CNCE

User Image Quantisnow Posted - 03/14/23

$CNCE Multiple insights just appeared: 1. 📜 SEC Form EFFECT filed by Concert Pharmaceuticals Inc. https://quantisnow.com/i/4196017?utm_source=stocktwits 2. 📜 SEC Form EFFECT filed by Concert Pharmaceuticals Inc. https://quantisnow.com/i/4196053?utm_source=stocktwits 3. 📜 SEC Form EFFECT filed by Concert Pharmaceuticals Inc. https://quantisnow.com/i/4196072?utm_source=stocktwits #healthcare

User Image Newsfilter Posted - 03/14/23

$CNCE filed 3 new form EFFECT (notice of effectiveness) with the SEC in the last 2 minutes. 1. filing: https://newsfilter.io/a/e43acc8672e0f41069aef783e13f0771 2. filing: https://newsfilter.io/a/a51cac15c07eb9b6db6e748db1f9f5bf 3. filing: https://newsfilter.io/a/d48183ba31131e0c9f5e9797732e1039

User Image Quantisnow Posted - 03/14/23

$CNCE 📜 SEC Form EFFECT filed by Concert Pharmaceuticals Inc. https://quantisnow.com/i/4196005?utm_source=stocktwits 45 seconds delayed.

User Image Newsfilter Posted - 03/14/23

$CNCE Form EFFECT (notice of effectiveness) filed with the SEC https://newsfilter.io/a/44bc3ec8d6264746c66822e55753e025

User Image risenhoover Posted - 03/13/23

$CNCE CNCE / Concert Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/cnce

User Image intratio Posted - 03/12/23

$CNCE https://www.intratio.com/stock-forecast/CNCE Concert Pharmaceuticals Inc The machine learning model computed that this company s stock price will have a negative trend in the short-term and has a dramatic negative long-term outlook

User Image MarketBeat Posted - 03/12/23

Concert Pharmaceuticals initiated by StockNews.com at sell. www.marketbeat.com/stocks/NASDAQ/CNCE/price-target/ $CNCE

User Image intratio Posted - 03/11/23

$CNCE Concert Pharmaceuticals Inc The AI has detected that this stock s price will have a short-term downward trend and has really poor long-term fundamentals

Analyst Ratings
JonesTrading Hold Jan 20, 23
Truist Securities Buy Sep 13, 22
JonesTrading Buy Aug 25, 22
Mizuho Buy Oct 5, 21
Truist Securities Buy Feb 2, 21
Berenberg Buy Dec 16, 20
H.C. Wainwright Buy Oct 3, 19
SunTrust Robinson Humphrey Buy Sep 30, 19
Mizuho Buy Sep 30, 19
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Stuart Nancy Chief Operating Offi.. Chief Operating Officer Feb 15 Sell 8.33 6,048 50,380 262,596 02/16/23
Munsie Jeffrey A Chief Legal Officer Chief Legal Officer Feb 15 Sell 8.34 3,762 31,375 88,049 02/16/23
Cassella James V Chief Development Of.. Chief Development Officer Feb 15 Sell 8.34 3,762 31,375 173,061 02/16/23
Becker Marc A. Chief Financial Offi.. Chief Financial Officer Feb 15 Sell 8.33 3,762 31,337 123,863 02/16/23
Stuart Nancy Chief Operating Offi.. Chief Operating Officer Jan 30 Sell 8.35 13,200 110,220 268,644 01/31/23
Munsie Jeffrey A Chief Legal Officer Chief Legal Officer Jan 30 Sell 8.35 8,493 70,917 91,811 01/31/23
Cassella James V Chief Development Of.. Chief Development Officer Jan 30 Sell 8.35 10,106 84,385 176,823 01/31/23
Becker Marc A. Chief Financial Offi.. Chief Financial Officer Jan 30 Sell 8.35 8,493 70,917 127,625 01/31/23
van Heek Christi Director Director Jun 06 Buy 4.75 10,526 49,998 25,651 06/06/22
Auchincloss Thomas G Director Director Jun 06 Buy 4.75 6,000 28,500 17,625 06/06/22
ALDRICH RICHARD Director Director Jun 06 Buy 4.75 210,526 999,998 210,526 06/06/22
Tung Roger D Chief Executive Offi.. Chief Executive Officer Feb 15 Sell 3.09 13,480 41,653 980,258 02/16/22
Stuart Nancy Chief Operating Offi.. Chief Operating Officer Feb 14 Sell 3.08 6,049 18,631 284,737 02/16/22
Munsie Jeffrey A Chief Legal Officer Chief Legal Officer Feb 14 Sell 3.09 3,762 11,625 103,197 02/16/22
Cassella James V Chief Development Of.. Chief Development Officer Feb 14 Sell 3.09 3,762 11,625 189,822 02/16/22
Becker Marc A. Chief Financial Offi.. Chief Financial Officer Feb 14 Sell 3.08 3,762 11,587 139,011 02/16/22
Tung Roger D Chief Executive Offi.. Chief Executive Officer Dec 13 Option 3.5 6,700 23,450 815,278 12/15/21
Tung Roger D Chief Executive Offi.. Chief Executive Officer Dec 13 Sell 3.62 6,700 24,254 808,578 12/15/21